The Drug Science Podcast20 Apr 2023

T21 - Medical Cannabis bonus episode

T21 (formerly Project Twenty21) is a pioneering medical cannabis registry launched in the United Kingdom in 2019. It aims to create the UK's largest body of evidence for the effectiveness and tolerability of medical cannabis in treating a range of conditions.

T21 focuses on patients with conditions that can be treated with medical cannabis such as chronic pain, anxiety conditions, epilepsy, multiple sclerosis, post-traumatic stress disorder (PTSD), Tourette's syndrome, and substance use disorder. A list of conditions that qualify for medical cannabis treatment can be found here. The registry provides patients with access to discounted medical cannabis from licensed producers and clinicians who have undergone training in the use of medical cannabis while collecting data to strengthen the evidence base The project is seen as a significant step forward in promoting research into the potential therapeutic benefits of medical cannabis, and in improving patient access to this treatment option in the UK.

In this very special episode of the Drug Science Podcast, we will be joined by three members of the Drug Science team:

David Badcock – Chief Executive Officer of Drug Science

Prof Michael Lynskey – Chief Research Officer

Alkyoni Athanasiou-Fragkouli – Research Officer for T21

*Please note that in this episode we make reference to a medical cannabis legal document that will be provided in the shownotes, this document is VERY close to being finished but it needs a few last-minute reviews to ensure that all of the information is 100% accurate, we appreciate your patience.

Meet the presenters!

Find out more about T21

David Nutt >< David Badcock Hepatitis C project

T21 latest data & data nuggets

T21 publications:

· Medication sparing after medical cannabis initiation: A case study of a chronic pain patient in Project Twenty21

· Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21

· Characteristics of People Seeking Prescribed Cannabinoids for the Treatment of Chronic Pain: Evidence From Project Twenty 21

· The value of real world evidence: The case of medical cannabis

· Preliminary findings from project Twenty21 Australia: An observational study of patients prescribed medicinal Cannabis for chronic pain, anxiety, posttraumatic stress disorder and multiple sclerosis

★ Support this podcast ★

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(160)

157. Psychedelics and Christianity with Wendi Rees

Trigger Warning: This episode contains discussions of childhood sexual abuse, trauma, suicidal thoughts, and mental health challenges. Listener discretion is advised. In this episode, Prof Jo Neill s...

19 Aug 57min

156. Training Grandmothers to Treat Depression with Dr Dixon Chibanda

In this episode, we speak with Dr Dixon Chibanda, a psychiatrist and professor at the London School of Hygiene and Tropical Medicine. He shares how losing a patient to suicide drove him towards commun...

5 Aug 41min

155. The History of Schizophrenia with Justin Garson

In this episode of the Drug Science Podcast, Dr Hannah Thurgur speaks with Dr Justin Garson, professor of philosophy at CUNY and the author of The Madness Pill, a history of Professor Solomon Snyder a...

22 Jul 47min

154. Is Medical Cannabis Over-Prescribed? with Dr Andy Barker

Join us in this episode as Prof Nutt speaks with Dr Andy Barker, a senior psychiatrist, medical cannabis prescriber, and the co-founder of This Native Mind. Andy shares his journey into medical cannab...

8 Jul 52min

153. Psychedelics, Couples and Sex with Sarah Tilley

In this episode, we speak with Sarah Tilley, a couple’s therapy pioneer and the CEO and founder of Beautiful Space, a provider of psilocybin programmes for couples. She details how her own divorce led...

24 Jun 42min

152. Cocaine and Alcohol with David Hillier

In this episode of the Drug Science Podcast, Prof Nutt speaks with David Hillier, a journalist and the creator of the Substack WHAT ARE YOU ON. David Hillier has been writing about drug culture and m...

10 Jun 38min

151. Francis Crick: From DNA to the Brain with Prof Matthew Cobb

In this episode, we speak to Prof Matthew Cobb, professor of zoology at the University of Manchester and author of Crick: A Mind in Motion, which profiles Francis Crick. Matthew shares insights into h...

27 Mai 57min

150. Synthetic Alcohol with David Orren

Join us in this episode of the Drug Science Podcast as Prof Jo Neill speaks with David Orren, CEO of GABA Labs, which has pioneered functional drinks with SENTIA Spirits. David recounts his initial co...

13 Mai 57min